Innovation That Breaks the Cycle of Pain

Alyea Therapeutics is pioneering investigational next-generation, non-opioid treatments that go beyond masking pain–we target its root cause to deliver lasting relief without addiction risks.

Medical Studies Backed by Science, Driven by Results

Leading institutions have studied Low Dose Naltrexone (LDN) as a breakthrough non-opioid pain treatment with strong safety and efficacy data.

Studying low-dose Naltrexone for chronic pain

Found LDN to be effective for orofacial and chronic pain without addiction risks

Research confirms LDN's superior safety and efficacy over traditional opioids

Low Dose Naltrexone

A novel, non-opioid drug with transformative potential, LDN has completed multiple clinical trials and is progressing toward regulatory approval as an Orphan Drug. Non-opioid pain medication is the Holy Grail of pharma, and LDN stands at the forefront of this movement.

Learn More

Alyea Clear Patch

An investigational topical pain relief technology designed for clear application and targeted pain relief. Pursued as both a branded formulation and an over the counter option, this innovative patch offers substantial market potential.

Learn More

“Patients deserve real pain relief without the fear of addiction. With Low Dose Naltrexone, we’re not just offering an alternative–we’re redefining the future of pain management.”

Dr. Amol Soin

CEO & Founder, Alyea Therapeutics